Latest Thailand News

Kingsgate Consolidated has converted a full year of Chatree mining into record financial results, with revenue up 77% and net profit reaching A$277.9 million. The balance sheet is stronger, dividends have returned and Nueva Esperanza is moving towards a feasibility decision, but higher waste movement and project execution now replace the turnaround story.

ReNerve’s October AGM presentation points to sharply higher sales, a growing US distribution network and a broader nerve repair pipeline. The company is also progressing a 240-patient NervAlign clinical study while relying on a $5 million RiverFort funding facility to support expansion.

Unity Metals has opened a non-renounceable share purchase plan targeting $1 million to fund gold and copper-gold exploration in Cambodia and Thailand. Eligible shareholders can buy shares at a 15.2% discount, with attaching options subject to a later shareholder vote.

Flagship Minerals has outlined a conceptual 22 million to 40 million tonne tungsten Exploration Target at its Khao Soon project in southern Thailand. The company is now weighing a sale, spin-out or joint venture for the non-core asset, but the target remains well short of a Mineral Resource.

Stakk Limited (ASX:SKK) delivered a sharp FY2026 revenue increase and moved to audited operating profitability, but its next test is considerably larger: integrating ParaScript while servicing new debt and converting contracted revenue into cash. The company is targeting A$55.2 million of pro forma revenue and A$18.5 million of EBITDA in FY2027.

Hastings Technology Metals has cut its annual loss sharply, but its latest report flags a material uncertainty over whether the pre-production rare earths company can secure the funding needed for Yangibana and its proposed Thai processing plant. The uncertainty comes as Wyloo seeks to sell its 60% Yangibana stake despite a study showing attractive project economics.

Unity Metals has secured an oversubscribed $3.5 million placement and plans a further $1 million share purchase plan to accelerate drilling across its Cambodian gold projects. The raise gives the explorer funding to test extensions at O’Phlay and new targets at Ngot, but also brings dilution and shareholder-approval hurdles.

Me Today reported a NZ$2.66 million FY26 profit, but the result was dominated by a NZ$4.12 million gain from losing control of King Honey. The remaining business grew revenue and improved its operating loss, yet continued to consume cash and will rely on October warrant funding.

Stakk says recurring contracts now support 100% of its approximately A$55.2 million FY2027 pro-forma revenue forecast, while fresh international wins are being built into the FY2028 growth story. The company will establish Singapore as its non-US commercial, service and technology hub from November 2026.

EVT delivered growth across hotels, cinemas and Thredbo in FY2026 while outlining an approximately $500 million non-core property divestment programme. The group is also reviewing its structure as it redirects capital towards asset-light hotel expansion and considers potential special dividends.

ReNerve has converted regulatory approvals into its first commercial NervAlign Nerve Cuff surgeries in Hong Kong and Malaysia, expanding activity to seven jurisdictions. The milestones arrive as FY26 sales climbed 88% to $510,357 and the company builds out its US distribution network.

Orthocell has recorded the first commercial sales of its Remplir nerve repair product in Thailand, opening a new market estimated at US$84 million. The launch gives the company another distributor-led growth channel, although near-term sales are expected to remain modest.